Budesonide Capsule, Coated Pellets
Product Images NDC 0904-7313

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Budesonide (NDC 0904-7313). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Major Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Budesonide (6325fb93 302b 443f Bc10 49e8c0e75b46 01)

This text provides information about two epimers of budesonide, specifically epimers 227 and 225. Budesonide is a medication often used to treat inflammatory conditions such as asthma and allergies. Epimers are stereoisomers that differ only in the configuration of a single stereogenic center.*

FDA Label Image

3mg Carton Label (E7aca8d1 159e 4aac B92d 3a69a8edceec 00)

This text appears to be a description of a medication called Budesonide Delayed-Release Capsules. The capsules are enteric-coated and each contains 3 mg of Budesonide, USP. The usual dosage instruction is to take 3 capsules every morning. The packaging contains 20 capsules. The medication is intended for institutional use only and should be stored at temperatures between 20°C to 25°C. Additional information can be found in the product insert. The medication is manufactured by Zydus Pharmaceuticals USA Inc.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.